• SENSEX 73,060.01
    -189.38 (--0.26%)
  • BANKNIFTY 54,925.70
    -51.20 (--0.09%)
  • SBI
    950.75 900.80(%)
  • Cyient
    1,268.00 1,226.25(%)
  • NSE
    1,640.25 1,683.00(%)
  • Eternal
    317.50 344.75(%)
  • Persistent Systems
    5,909.85 6,597.00(%)
  • Swiggy
    174.90 207.75(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,015.20(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Divi's Lab.
    8,800.00 5,648.00(%)
  • PC Jeweller
    17.08 7.45(%)
  • Steel Str. Wheel
    469.70 434.05(%)
  • Reliance Industries
    1,201.95 1,611.20(%)
  • Ventive Hospital
    566.35 798.45(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Indian Hotels Co
    765.00 565.25(%)
  • Max Healthcare
    819.80 1,221.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anlon Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 94105.0
  • ISIN : INE0Y8W01025
24.35 -1 (-4.99%)
  • As on 23 Oct 2026 (EOD)

  • Today’s Low

    24.35

  • Today’s High

    25.74

  • Open

    25.30

  • Perv Close

    25.63

  • 52W Low

    10.37

  • 52W High

    37.24

Key Indicators

  • P/E(TTM)

    44.27

  • Mar.Cap (₹Cr.)

    1,294.24

  • Div & Yield %

    0.00

  • Book Value(₹)

    3.95

  • Debt-Equity Ratio

    -4.99

  • AGM Date

    22-Oct-2026

  • EPS

    0.55

  • P/E Ratio

    44.27

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,294.24

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    106.30

  • BV (₹)

    3.90

  • Sales( ₹ in Cr.)

    176.50

  • NP (in Cr.)

    27.81

  • NP Var(%)

    36.0

  • Div%

    0.0

  • CPS (₹)

    0.50

  • EPS (₹)

    0.50

  • Traded Value (₹ in Lakhs)

    1,294.24

  • 52 Week High

    37.24

  • 52 Week Low

    10.37

  • Price BSE

    24.0

  • Price NSE

    24.00

  • Market Capital( in Cr.)

    1,294.24

  • P/C Ratio

    43.70

  • P/E Ratio

    45.90

  • Price Vs.BV

    0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 176.50 120.29 66.58 112.88 57.14 15.98
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 176.50 120.29 66.58 112.88 57.14 15.98
Other Income 0.25 0.17 0.11 0.24 0.39 0.35
Stock Adjustments 16.92 -3.30 10.39 -2.44 4.16 3.24
Total Income 193.67 117.16 77.08 110.68 61.69 19.57
EXPENDITURE :            
Raw Materials 129.76 71.29 44.05 85.51 47.49 15.06
Power and Fuel Cost 3.49 2.87 4.04 3.82 2.10 2.14
Employee Cost 5.25 4.88 4.36 3.68 2.78 3.08
Other Manufacturing Expenses 3.72 1.64 4.17 1.56 1.42 2.06
Selling and Administration Expenses 2.32 2.18 3.97 2.42 1.61 1.87
Miscellaneous Expenses 2.73 1.92 0.68 0.91 0.35 0.20
Employee Benefit Expenses 5.25 4.88 4.36 3.68 2.78 3.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 147.27 84.78 61.27 97.89 55.74 24.41
Operating Profit 46.39 32.38 15.81 12.79 5.94 -4.84
Interest 4.35 3.72 4.17 3.93 4.21 3.21
Gross Profit 42.04 28.66 11.64 8.86 1.73 -8.05
Depreciation 1.36 1.77 1.89 1.87 1.84 1.86
Profit Before Tax 40.68 26.89 9.75 6.99 -0.11 -9.91
Current Tax 11.40 6.54 0.01 1.01 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.47 -0.17 0.08 0.16 0.00 0.33
Reported Net Profit 27.81 20.52 9.66 5.82 -0.11 -10.24
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -0.02
Adjusted Net Profit 27.81 20.52 9.66 5.82 -0.11 -10.22
Adjustment below Net Profit 5.48 0.01 0.00 0.00 -0.21 0.00
P & L Balance brought forward 23.04 2.52 -7.51 -13.33 -13.02 -2.98
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 56.33 23.04 2.14 -7.51 -13.33 -13.22
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.23 5.15 6.04 4.85 -0.09 -8.53
Earnings Per Share(Adj)-Unit Curr 0.52 - - - - -
Book Value 39.47 20.18 13.14 6.15 1.30 1.39
Book Value(Adj)-Unit Curr 3.95 - - - - -

Shareholding Pattern

  • Promoter Group

    52.68%

  • Public Share Holding

    47.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 280,000,000 52.68 280,000,000 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 280,000,000 52.68 280,000,000 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,303,534 1.00 5,303,534 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 300,000 0.06 300,000 1
Mutual Funds / UTI 10,203 0.00 10,203 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,290,000 0.24 1,290,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,903,737 1.30 6,903,737 10
2] Non Institution
Bodies Corporate 78,762,620 14.82 78,762,620 135
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,427,352 1.21 6,427,352 469
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 4,006,966 0.75 4,006,966 570
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 75,613,267 14.23 75,613,267 173
Individuals holding nominal share capital up to Rs. 1 lakh 79,801,058 15.01 79,798,058 79,997
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 244,611,263 46.02 244,608,263 81,344
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 531,515,000 100.00 531,512,000 81,356

Company Background

Anlon Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Anlon Healthcare Ltd
  • BSE Code : 94105.0
  • ISIN : INE0Y8W01025

  • Incorporation Year

    2013

  • Registered Office

    101/102 Silvercoin Complex Opp
    Crystal Mall Kalawad Road, Rajkot,
    Gujarat-360005

  • Telephone

    +91 281 2562538/39

  • FAX

  • Chairman

    Punitkumar R Rasadia

  • Managing Director

    Punitkumar R Rasadia

  • Company Secretary

    Pragada Amitabhen Chhaganbha

  • Auditor

    RVD & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Anlon Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anlon Healthcare 24.35 176.75 176.50 44.27 22.35
Abbott India 25,393.50 7,217.19 6,929.05 33.42 43.78
Astrazeneca Phar 6,098.65 2,304.07 2,275.58 89.88 27.86
Glaxosmi. Pharma 2,434.70 3,932.76 3,790.20 38.89 58.17
Novartis India 1,686.70 393.10 354.33 42.59 15.94
Cipla 1,329.90 20,102.60 18,979.95 34.95 13.88
Bliss GVS Pharma 640.25 773.53 729.81 59.50 12.51
Amrutanjan Healt 495.80 520.13 502.55 26.56 24.16
Fermenta Biotec. 457.40 474.15 450.25 21.35 18.77
Guj. Themis Bio. 355.10 168.25 165.82 94.95 18.05
Ambalal Sarabhai 36.28 19.52 3.94 67.19 6.77